GenomeWeb picked up our announcement and reports on LexaGene’s cooperative research agreement with the US Army:
MiQLab is an RT-PCR sample-to-answer system developed for veterinary diagnostic and food safety applications. Amid the COVID-19 pandemic, LexaGene has also been exploring its use for the detection of SARS-CoV-2 and other human pathogens.
Under the terms of their Cooperative Research and Development Agreement, or CRADA, DEVCOM and LexaGene will test the MiQLab system’s ability to detect two biothreats — Bacillus anthracis, which causes anthrax, and Yersinia pestis, which causes plague — focusing on its sensitivity and quantitative detection capability.
